-+ 0.00%
-+ 0.00%
-+ 0.00%

Aprogen trims Aprogen Biologics stake to 91.63% from 91.70% filing shows

PUBT·10/08/2026 08:26:29
Listen to the news
Aprogen trims Aprogen Biologics stake to 91.63% from 91.70% filing shows
  • Aprogen Biologics’ controlling shareholder Aprogen cut its stake to 89,461,681 shares, or 91.63%, as of Oct. 7.
  • The prior filing showed 90,255,836 shares, or 91.70%, implying a decrease of 794,155 shares.
  • The change was driven by a related party’s sale of Aprogen Biologics convertible bonds.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aprogen Biologics Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261008000508), on October 08, 2026, and is solely responsible for the information contained therein.